The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-15 of 15 articles
DAPT guided by platelet function tests or genotyping after PCI: pros and cons
September 18, 2023 | 10.4244/EIJ-E-23-00022
P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET Trial
Guimarães PO,
Franken M,
Tavares CAM,
Silveira FS,
Antunes MO,
Bergo RR,
Joaquim RM,
Hirai JC,
Andrade PB,
Pitta FG,
Mariani Jr. J,
Nascimento BR,
de Paula JE,
Silveira MS,
Costa TA,
Dall’Orto FT,
Serpa RG,
Sampaio FB,
Ohe LN,
Mangione FM,
Furtado RH,
Sarmento-Leite R,
Monfardini F,
Assis SR,
Nicolau JC,
Sposito AC,
Lopes RD,
Onuma Y,
Valgimigli M,
Angiolillo D,
Serruys P,
Berwanger O,
Bacal F,
Lemos PA
July 17, 2023 | 10.4244/EIJ-D-23-00125
Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled study
Franchi F,
Ortega-Paz L,
Rollini F,
Been L,
Rivas A,
Maaliki N,
Zhou X,
Pineda A,
Suryadevara S,
Soffer D,
Zenni M,
Angiolillo D
March 20, 2023 | 10.4244/EIJ-D-22-00719
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study
Sardella G,
Beerkens F,
Dangas G,
Cao D,
Baber U,
Sartori S,
Cohen D,
Briguori C,
Gil R,
Nicolas J,
Zhang Z,
Dudek D,
Kunadian V,
Kornowski R,
Weisz G,
Claessen B,
Marx S,
Escaned J,
Huber K,
Collier T,
Moliterno D,
Ohman EM,
Krucoff M,
Kastrati A,
Steg G,
Angiolillo D,
Mehta SR,
Shlofmitz RA,
Sharma S,
Pocock S,
Gibson C,
Mehran R
December 2, 2022 | 10.4244/EIJ-D-22-00319
Antiplatelet therapy after percutaneous coronary intervention
April 1, 2022 | 10.4244/EIJ-D-21-00904
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study
Dangas G,
Baber U,
Sharma S,
Giustino G,
Sartori S,
Nicolas J,
Goel R,
Mehta SR,
Cohen D,
Angiolillo D,
Zhang Z,
Camaj A,
Cao D,
Briguori C,
Dudek D,
Escaned J,
Huber K,
Collier T,
Kornowski R,
Kunadian V,
Moliterno D,
Ohman EM,
Weisz G,
Gil R,
Krucoff M,
Kaul U,
Oldroyd K,
Sardella G,
Shlofmitz RA,
Witzenbichler B,
Kastrati A,
Han Y,
Steg G,
Pocock S,
Gibson CM,
Mehran R
March 18, 2022 | 10.4244/EIJ-D-21-00721
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions
Zimarino M,
Angiolillo D,
Dangas G,
Capodanno D,
Barbato E,
Hahn J,
Giustino G,
Watanabe H,
Costa F,
Cuisset T,
Rossini R,
Sibbing D,
Burzotta F,
Louvard Y,
Shehab A,
Renda G,
Kimura T,
Gwon H,
Chen S,
Costa R,
Koo B,
Storey R,
Valgimigli M,
Mehran R,
Stankovic G
May 16, 2021 | 10.4244/EIJ-D-20-00885
Crushed ticagrelor in comatose patients treated with primary percutaneous coronary intervention
February 20, 2017 | 10.4244/EIJV12I14A276
Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention
De Servi S,
Crimi G,
Calabrò P,
Piscione F,
Cattaneo M,
Maffeo D,
Toso A,
Bartorelli AL,
Palmieri C,
De Carlo M,
Capodanno D,
Barozzi C,
Tomasi L,
Della Riva D,
Angiolillo D,
Palmerini T
June 20, 2016 | 10.4244/EIJV12I3A51
Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies
Rossini R,
Musumeci G,
Visconti L,
Bramucci E,
Castiglioni B,
De Servi S,
Lettieri C,
Lettino M,
Piccaluga E,
Savonitto S,
Trabattoni D,
Capodanno D,
Buffoli F,
Parolari A,
Dionigi G,
Boni L,
Biglioli F,
Valdatta L,
Droghetti A,
Bozzani A,
Setacci C,
Ravelli P,
Crescini C,
Staurenghi G,
Pietro Scarone P,
Francetti L,
D’Angelo F,
Gadda F,
Comel A,
Salvi L,
Lorini L,
Antonelli M,
Bovenzi F,
Cremonesi A,
Angiolillo D,
Guagliumi G
May 20, 2014 | 10.4244/EIJV10I1A8
Sirolimus-eluting stent versus bare metal stent in diabetic patients: the final five-year follow-up of the DIABETES trial
Jiménez-Quevedo P,
Hernando L,
Gomez-Hospital J,
Iñiguez A,
San Román A,
Alfonso F,
Hernández-Antolín R,
Angiolillo D,
Banuelos C,
Escaned J,
Gonzalo N,
Fernandez C,
Macaya C,
Sabaté M
July 26, 2013 | 10.4244/EIJV9I3A54
Latest news
NEW ISSUE
The Bifurcation ARC consensus; impact of P2Y12 de-escalation in HBR; 5-year outcomes of the TARGET trial and more...
December 4, 2023
STATE-OF-THE-ART
Free access collection all year long
December 4, 2023
AHEAD OF PRINT
Poor improvement of post-PCI iFR in LAD
FREE ARTICLE - Mitsuaki Matsumura et al
November 30, 2023
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
PCR London Valves 2023
November 16, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023